Oral Ketorolac Dosing for Renal Stone Pain
For renal colic, oral ketorolac should be dosed at 20 mg once, followed by 10 mg every 4-6 hours as needed (maximum 40 mg/day), but only as continuation therapy after initial IV or IM ketorolac administration, with total treatment duration not exceeding 5 days. 1
Critical FDA-Mandated Restrictions
- Oral ketorolac is NOT approved as initial therapy for renal colic—it must be preceded by IV or IM ketorolac administration 1
- The combined duration of parenteral plus oral ketorolac cannot exceed 5 days total 1
- Oral formulation should never be given as the first dose 1
Standard Dosing Protocol
For patients aged 17-64 years:
- Initial oral dose: 20 mg once
- Maintenance: 10 mg every 4-6 hours as needed
- Maximum daily dose: 40 mg
- Do not shorten the 4-6 hour dosing interval 1
Mandatory Dose Reductions
Reduce to 10 mg initial dose (then 10 mg every 4-6 hours, maximum 40 mg/day) for patients who are: 1
- Age ≥65 years
- Weight <50 kg (110 lbs)
- Any degree of renal impairment
Absolute Contraindications
- Creatinine clearance <30 mL/min or GFR <30 mL/min/1.73 m² 2
- Severe renal impairment 3
- Active peptic ulcer disease or acute GI hemorrhage 4
High-Risk Populations Requiring Extreme Caution
Elderly patients (≥65 years) receiving diuretics, ACE inhibitors/ARBs, or with baseline creatinine elevation face substantially higher risk of acute kidney injury 2. For patients with GFR 30-60 mL/min/1.73 m², prolonged NSAID therapy is discouraged; short-term use may be considered only with extreme caution 2.
Clinical Context: Why This Matters
While NSAIDs are highly effective for renal colic—with ketorolac demonstrating equivalent or superior efficacy to opioids 5, 6—the oral formulation has significant regulatory restrictions. The FDA mandates IV or IM initiation because renal colic typically presents with severe pain requiring rapid onset analgesia 1. Studies show IV ketorolac provides clinically meaningful pain reduction within 30 minutes 7, whereas oral absorption would delay this effect.
Common pitfall: Prescribing oral ketorolac as monotherapy for acute renal colic violates FDA labeling and delays adequate pain control 1.
Alternative First-Line Approaches
For primary care or outpatient settings where IV/IM administration is impractical, consider:
- Intramuscular diclofenac 75 mg as the preferred injectable NSAID 3
- Oral NSAIDs (ibuprofen 400-800 mg) are acceptable first-line agents despite ketorolac's restrictions 3, 8
- Ensure adequate hydration to reduce renal adverse events 2